Clinical trial
LEO19123 Cream in the Treatment of Atopic Dermatitis
NCT00392067 · LEO Pharma, Industry · Completed
Key facts
| NCT number | NCT00392067 |
|---|---|
| Title | LEO19123 Cream in the Treatment of Atopic Dermatitis |
| Official title | LEO19123 Cream in the Treatment of Atopic Dermatitis |
| Lead sponsor | LEO Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atopic Dermatitis |
| Intervention type | Drug |
| Interventions | Calcipotriol and LEO80122 (LEO19123 cream) |
| Enrollment | 75 |
| Start date | Oct 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Oct 25, 2006 |
| Last update posted | Feb 24, 2025 |
| Countries | Canada, Denmark, Finland, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: